Subclinical intestinal inflammation in chronic granulomatous disease patients

Immunologic Research

Volumn 64, Issue 1, 2016, Pages 155-159

  Broides, Arnon ^a,b   Sagi, Orli ^a,b   Pinsk, Vered ^a,b   Levy, Jacov ^a,b   Yerushalmi, Baruch ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Calprotectin; Chronic granulomatous disease; Colitis; Inflammatory bowel disease

Indexed keywords

CALGRANULIN; FUNGUS ANTIBODY; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; ASYMPTOMATIC DISEASE; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENTERITIS; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; CHEMISTRY; COMPLICATION; FECES; GRANULOMATOUS DISEASE, CHRONIC; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; NEUTROPHIL; PROGNOSIS;

ADOLESCENT; ASYMPTOMATIC DISEASES; BIOMARKERS; CHILD; CHILD, PRESCHOOL; COLITIS; FECES; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INTESTINAL MUCOSA; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; NEUTROPHILS; PROGNOSIS;

EID: 84955667145     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8733-2     Document Type: Article

References (24)

1. Leiding JW, Holland SM. Chronic granulomatous disease 2012 Aug 09. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews™ [Internet]. Seattle: University of Washington; 1993–2013. http://www.ncbi.nlm.nih.gov/books/NBK99496/, PubMed PMID: 22876374.
2. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS ONE. 2009;4:e5234. doi:10.1371/journal.pone.0005234.
3. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.
4. Jones LB, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211–8.
5. Magnani A, Brosselin P, Beauté J, de Vergnes N, Mouy R, Debré M, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134(655–62):e8.
6. Broides A, Mohammed R, Reid B, Roifman CM, Grunebaum E. Gastrointestinal abnormalities among patients with chronic granulomatous disease. J Clin Cell Immunol. 2014. doi:10.4172/2155-9899.1000204.
7. Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–8.
8. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64.
9. Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168:149–55.
10. Huang JS, Noack D, Rae J, Ellis BA, Newbury R, Pong AL, et al. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn’s disease. Clin Gastroenterol Hepatol. 2004;2(8):690–5.
11. Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104:117–24.
12. Freudenberg F, Wintergerst U, Roesen-Wolff A, Albert MH, Prell C, Strahm B, et al. Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. J Allergy Clin Immunol. 2010;125(943–6):e1.
13. Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, et al. High levels of Crohn’s disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol. 2011;138:14–22.
14. Henderson P, Anderson NH, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:637–45.
15. Montalto M, Gallo A, Santoro L, D’Onofrio F, Landolfi R, Gasbarrini A. Role of fecal calprotectin in gastrointestinal disorders. Eur Rev Med Pharmacol Sci. 2013;17:1569–82.
16. Bianchi M, Niemiec MJ, Siler U, Urban CF, Reichenbach J. Restoration ofanti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J Allergy Clin Immunol. 2011;127:1243–52.
17. Benor S, Russell GH, Silver M, Israel EJ, Yuan Q, Winter HS. Shortcomings of the inflammatory bowel disease serology 7 panel. Pediatrics. 2010;125:1230–6.
18. Soncini E, Slatter MA, Jones LB, Hughes S, Hodges S, Flood TJ, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol. 2009;145:73–83.
19. Ahlin A, Fasth A. Chronic granulomatous disease—conventional treatment versus hematopoietic stem cell transplantation: an update. Curr Opin Hematol. 2015;22:41–5.
20. Alimchandani M, Lai JP, Aung PP, Khangura S, Kamal N, Gallin JI, et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013;37:1365–72.
21. Levine S, Smith VV, Malone M, Sebire NJ. Histopathological features of chronic granulomatous disease (CGD) in childhood. Histopathology. 2005;47:508–16.
22. Jaggi P, Freeman AF, Katz BZ. Chronic granulomatous disease presenting with eosinophilic inflammation. Pediatr Infect Dis J. 2005;24:1020–1.
23. Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998;102:2146–55.
24. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol. 2012;2012:252460.